Archives: ClinicianPOV

Androgen Receptor Inhibitors: A Novel Therapeutic Option for Nonmetastatic, Castration-Resistant Prostate Cancer

This Q&A was edited for clarity and length. Disclosure Cora N. Sternberg, MD, reported affiliations with Astellas Pharma, Inc; AstraZeneca PLC; Bayer AG; Gilead Sciences, Inc; Incyte; Merck & Co, Inc; MSD; Pfizer, Inc; Roche Holding AG; Impact Pharmaceutical Services; Bristol Myers Squibb; and Sanofi-Genzyme. References Hussain M, Fizazi K, Saad F, et al. Enzalutamide…